Adage Capital Partners’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64M | Buy |
|
|||||
|
2025
Q1 | $33.6M | Buy |
|
|||||
|
2024
Q4 | $42.8M | Buy |
|
|||||
|
2024
Q3 | $30.3M | Buy |
|
|||||
|
2024
Q2 | $31.2M | Sell |
|
|||||
|
2024
Q1 | $98.3M | Buy |
|
|||||
|
2023
Q4 | $103M | Buy |
|
|||||
|
2023
Q3 | $13.9M | Sell |
|
|||||
|
2023
Q2 | $15.5M | Sell |
|
|||||
|
2023
Q1 | $5.73M | Hold |
|
|||||
|
2022
Q4 | $6.83M | Hold |
|
|||||
|
2022
Q3 | $15.4M | Hold |
|
|||||
|
2022
Q2 | $15.3M | Hold |
|
|||||
|
2022
Q1 | $23.7M | Hold |
|
|||||
|
2021
Q4 | $23.9M | Buy |
|
|||||
|
2021
Q3 | $18.4M | Buy |
|
|||||
|
2021
Q2 | $14.4M | Buy |
|
|||||
|
2021
Q1 | $15.4M | Buy |
|